Compare DRDB & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRDB | PROF |
|---|---|---|
| Founded | 2024 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.5M | 270.7M |
| IPO Year | N/A | 2017 |
| Metric | DRDB | PROF |
|---|---|---|
| Price | $10.46 | $5.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 456.4K | 274.5K |
| Earning Date | 01-01-0001 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.89 |
| EPS | N/A | ★ 1.41 |
| Revenue | N/A | ★ $16,098,000.00 |
| Revenue This Year | N/A | $115.41 |
| Revenue Next Year | N/A | $60.63 |
| P/E Ratio | $597.54 | ★ $3.60 |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $9.96 | $3.90 |
| 52 Week High | $10.55 | $8.95 |
| Indicator | DRDB | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 52.60 | 35.61 |
| Support Level | $10.42 | $4.09 |
| Resistance Level | $10.47 | $5.98 |
| Average True Range (ATR) | 0.01 | 0.50 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 33.33 | 9.70 |
Roman DBDR Acquisition Corp II is a blank check company.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.